Curcumin has demonstrated anti-inflammatory properties and has been investigated as an
adjuvant therapy of ulcerative colitis (UC). The scope of this study was to systematically …

Rationale: Two antifibrotic medications, nintedanib and pirfenidone, have been approved for
the treatment of idiopathic pulmonary fibrosis (IPF) in the United States. Few data have been …

Mesenchymal stromal/stem cells (MSCs) have a great potential to proliferate, undergo multi‐
directional differentiation, and exert immunoregulatory effects. There is already much …

Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterised by a
progressive and irreversible decline in lung function, which is associated with poor long …

Background Pirfenidone and nintedanib are the only disease-modifying treatments available
for idiopathic pulmonary fibrosis (IPF). Our aim was to test their effectiveness and safety in …

Lead-like drugs, or drugs below molecular weight 300, are an important and sometimes
overlooked component of the current pharmacopeia and contemporary medicinal chemistry …

Although the clinical application of new drugs has been shown to be effective in slowing
disease progression and improving the quality of life in patients with pulmonary fibrosis, the …

Rationale: The diagnosis of idiopathic pulmonary fibrosis (IPF) remains challenging and can
result in delayed or misdiagnosis. IPF diagnosis is based on the presence of either a …

(1) Objective: Our objective was to conduct a meta-analysis of randomized controlled trials
that have evaluated the benefits of exercise training for elderly pulmonary fibrosis (PF) …

Pulmonary vascular endothelial dysfunction is a key pathogenic mechanism in acute
respiratory distress syndrome (ARDS), resulting in fibrosis in lung tissues, including in the …